Drugs that can upregulate the expression of ACE2, such as ARBs and ACE inhibitors, have been commonly used in patients with hypertension and other cardiovascular diseases to regulate blood pressure and reduce the mortality and morbidity events (Gulet al., 2021;Shibataet al., 2020;Yanget al., 2020). The gene discussed is ACE; the disease is cardiovascular disorder.